Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Fenfluramine hydrochloride

Related Products

Hot Products

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.
Name

Fenfluramine hydrochloride

EINECS 206-968-2
CAS No. 404-82-0 Density N/A
PSA 12.03000 LogP 3.63680
Solubility N/A Melting Point 1660C
Formula C12H17ClF3N Boiling Point 243.1 °C at 760 mmHg
Molecular Weight 267.722 Flash Point 100.8 °C
Transport Information N/A Appearance Crystalline Solid
Safety 7-16-36/37-45-36/37/39-22 Risk Codes 25-23/24/25
Molecular Structure Molecular Structure of 404-82-0 (Fenfluramine hydrochloride) Hazard Symbols T
Synonyms

Benzeneethanamine,N-ethyl-a-methyl-3-(trifluoromethyl)-,hydrochloride (9CI);1-(m-Trifluoromethylphenyl)-2-(ethylamino)propane hydrochloride;Fenfluraminehydrochloride;HHR-965;N-Ethyl-a-methyl-m-(trifluoromethyl)phenethylaminehydrochloride;Ponderal;Ponderax;Ponderex;Pondimin;Fenfluramine hydrochloride;

Article Data 4

Fenfluramine hydrochloride Specification

Fenfluramine hydrochloride is a drug that suppresses appetite by altering brain levels of serotonin, formerly used in the management of obesity. With the CAS NO.404-82-0, it is also called Phenfluoramine hydrochloride; Ponderal; Ponderax; Pondimin.  And it should be stored in airtight containers.

Physical properties about Fenfluramine hydrochloride are: (1)ACD/LogP: 3.047; (2)ACD/LogD (pH 5.5): -0.04; (3)ACD/LogD (pH 7.4): 0.40; (4)ACD/BCF (pH 5.5): 1.00; (5)ACD/BCF (pH 7.4): 1.00; (6)ACD/KOC (pH 5.5): 1.00; (7)ACD/KOC (pH 7.4): 2.45; (8)#H bond acceptors: 1 ; (9)#H bond donors: 1; (10)#Freely Rotating Bonds: 4; (11)Flash Point: 100.8 °C ; (12)Enthalpy of Vaporization: 48.01 kJ/mol; (13)Boiling Point: 243.1 °C at 760 mmHg; (14)Vapour Pressure: 0.0327 mmHg at 25°C

Uses of Fenfluramine hydrochloride: Fenfluramine hydrochloride is used as slimming products. Apply to simple obesity. The blood drug levels reached steady state after 3-4d, resulting in efficacy. It is a compound that specifically inhibits the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent.

When you are using this chemical, please be cautious about it as the following:
1. Keep container tightly closed;
2. Keep away from sources of ignition - No smoking;
3. Wear suitable protective clothing and gloves;
4. In case of accident or if you feel unwell, seek medical advice immediately (show label where possible);

You can still convert the following datas into molecular structure:
(1)InChI=1S/C12H16F3N.ClH/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15;/h4-6,8-9,16H,3,7H2,1-2H3;1H;
(2)InChIKey=ZXKXJHAOUFHNAS-UHFFFAOYSA-N;
(3)Smilesc1(cccc(c1)C(F)(F)F)C[C@@H](C)NCC.Cl;

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD50 oral 60mg/kg (60mg/kg) BEHAVIORAL: REGIDITY

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: TREMOR
Toxicology and Applied Pharmacology. Vol. 19, Pg. 705, 1971.
 
child LDLo oral 70mg/kg (70mg/kg) CARDIAC: OTHER CHANGES Clinical Toxicology. Vol. 14, Pg. 97, 1979.
 
dog LD50 intravenous 23mg/kg (23mg/kg) BEHAVIORAL: EXCITEMENT

BEHAVIORAL: ALTERATION OF CLASSICAL CONDITIONING

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Toxicology and Applied Pharmacology. Vol. 14, Pg. 182, 1969.
 
dog LD50 oral 100mg/kg (100mg/kg) BEHAVIORAL: REGIDITY

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: TREMOR
Toxicology and Applied Pharmacology. Vol. 19, Pg. 705, 1971.
 
guinea pig LD50 intraperitoneal 100mg/kg (100mg/kg) BEHAVIORAL: REGIDITY

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: TREMOR
Toxicology and Applied Pharmacology. Vol. 19, Pg. 705, 1971.
 
human TDLo oral 7mg/kg (7mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
British Medical Journal. Vol. 1, Pg. 740, 1967.
 
mouse LD50 intraperitoneal 92mg/kg (92mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: FOOD INTAKE (ANIMAL)
Arzneimittel-Forschung. Drug Research. Vol. 28, Pg. 1561, 1978.
 
mouse LD50 intravenous 90mg/kg (90mg/kg) BEHAVIORAL: REGIDITY

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: TREMOR
Toxicology and Applied Pharmacology. Vol. 19, Pg. 705, 1971.
 
mouse LD50 oral 170mg/kg (170mg/kg)   Therapie. Vol. 20, Pg. 297, 1965.
 
rabbit LD50 oral 50mg/kg (50mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: REGIDITY

BEHAVIORAL: TREMOR
Toxicology and Applied Pharmacology. Vol. 19, Pg. 705, 1971.
 
rat LD50 intraperitoneal 90mg/kg (90mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: REGIDITY
Toxicology and Applied Pharmacology. Vol. 19, Pg. 705, 1971.
 
rat LD50 oral 69mg/kg (69mg/kg) BEHAVIORAL: FLUID INTAKE Toxicology and Applied Pharmacology. Vol. 14, Pg. 182, 1969.
 
women TDLo oral 36mg/kg (36mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: SLEEP

SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
Journal of Toxicology, Clinical Toxicology. Vol. 33, Pg. 161, 1995.